Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics vs Surgery for Appendicitis Pilot
NCT02447224Phase 1Completed
- Sponsor
- Olive View-UCLA Education & Research Institute
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ertapenem, cefdinir and metronidazole in acute appendicitis (2 arms), sponsored by Olive View-UCLA Education & Research Institute. Primary endpoint: Major Complications at 30 days. Started Mar 2015; status: completed.
02
Drugs
ertapenemcefdinirmetronidazole
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT02447224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447224.